56546-36-2,MFCD05863303
Catalog No.:AA00EDOP

56546-36-2 | (2-Oxopyridin-1(2h)-yl)acetic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$91.00   $64.00
- +
1g
95%
in stock  
$172.00   $120.00
- +
5g
95%
in stock  
$685.00   $479.00
- +
10g
98%
in stock  
$1,075.00   $753.00
- +
25g
98%
in stock  
$2,299.00 $1,609.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00EDOP
Chemical Name:
(2-Oxopyridin-1(2h)-yl)acetic acid
CAS Number:
56546-36-2
Molecular Formula:
C7H7NO3
Molecular Weight:
153.1354
MDL Number:
MFCD05863303
SMILES:
OC(=O)Cn1ccccc1=O
Properties
Properties
 
BP:
440.8°C at 760 mmHg  
Form:
Solid  
MP:
220-223 °C  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
242  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0  

Downstream Synthesis Route
58333-75-8    56546-36-2   
1-(2-(4-(2-methoxyphenyl)piperidin-1-yl)-2-oxoethyl)pyridin-2(1H)-one 

[1]Patent:WO2018/136555,2018,A2.Locationinpatent:Paragraph0285

56546-36-2    223673-36-7   
(R)-(2-hydroxy-2-phenylethyl)(4-(2-(2-oxopyridine-1(2H)-yl)acetylamino)phenethyl)carbamicacidtert-butylester 

[1]Patent:CN109761892,2019,A.Locationinpatent:Paragraph0213;0234-0237

56546-36-2    42456-82-6   
N‐(1‐methyl‐1H‐indol‐2‐yl)‐2‐(2‐oxo‐1,2‐dihydropyridin‐1‐yl)acetamide 

[1]Leino,TeppoO.;Sieger,Peter;Yli-Kauhaluoma,Jari;Kley,JörgT.;Wallén,ErikA.A.[EuropeanJournalofMedicinalChemistry,2022,vol.237]

[2]Leino,TeppoO.;Sieger,Peter;Yli-Kauhaluoma,Jari;Kley,JörgT.;Wallén,ErikA.A.[EuropeanJournalofMedicinalChemistry,2022,vol.237]

Literature

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters 20101101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:56546-36-2 Molecular Formula|56546-36-2 MDL|56546-36-2 SMILES|56546-36-2 (2-Oxopyridin-1(2h)-yl)acetic acid
Catalog No.: AA00EDOP
56546-36-2,MFCD05863303
56546-36-2 | (2-Oxopyridin-1(2h)-yl)acetic acid
Pack Size: 250mg
Purity: 98%
in stock
$91.00 $64.00
Pack Size: 1g
Purity: 95%
in stock
$172.00 $120.00
Pack Size: 5g
Purity: 95%
in stock
$685.00 $479.00
Pack Size: 10g
Purity: 98%
in stock
$1,075.00 $753.00
Pack Size: 25g
Purity: 98%
in stock
$2,299.00 $1,609.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00EDOP
Chemical Name: (2-Oxopyridin-1(2h)-yl)acetic acid
CAS Number: 56546-36-2
Molecular Formula: C7H7NO3
Molecular Weight: 153.1354
MDL Number: MFCD05863303
SMILES: OC(=O)Cn1ccccc1=O
Properties
BP: 440.8°C at 760 mmHg  
Form: Solid  
MP: 220-223 °C  
Storage: Keep in dry area;2-8℃;  
Complexity: 242  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 11  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0  
Downstream Synthesis Route
58333-75-8    56546-36-2   
1-(2-(4-(2-methoxyphenyl)piperidin-1-yl)-2-oxoethyl)pyridin-2(1H)-one 

[1]Patent:WO2018/136555,2018,A2.Locationinpatent:Paragraph0285

56546-36-2    223673-36-7   
(R)-(2-hydroxy-2-phenylethyl)(4-(2-(2-oxopyridine-1(2H)-yl)acetylamino)phenethyl)carbamicacidtert-butylester 

[1]Patent:CN109761892,2019,A.Locationinpatent:Paragraph0213;0234-0237

56546-36-2    42456-82-6   
N‐(1‐methyl‐1H‐indol‐2‐yl)‐2‐(2‐oxo‐1,2‐dihydropyridin‐1‐yl)acetamide 

[1]Leino,TeppoO.;Sieger,Peter;Yli-Kauhaluoma,Jari;Kley,JörgT.;Wallén,ErikA.A.[EuropeanJournalofMedicinalChemistry,2022,vol.237]

[2]Leino,TeppoO.;Sieger,Peter;Yli-Kauhaluoma,Jari;Kley,JörgT.;Wallén,ErikA.A.[EuropeanJournalofMedicinalChemistry,2022,vol.237]

Literature fold

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Building Blocks More >
60060-44-8
60060-44-8
2-Bromocyclohexane-1,3-dione
AA00EDSS | MFCD00971951
61799-79-9
61799-79-9
4-Bromo-N,2-dihydroxybenzamide
AA00EDWQ | MFCD23715456
61711-87-3
61711-87-3
1-(2-Aminopropoxy)-4-methylbenzene
AA00EE12 | MFCD06248348
59301-24-5
59301-24-5
5-(m-Tolyl)-4H-1,2,4-triazol-3-amine
AA00EE4M | MFCD05182346
61491-92-7
61491-92-7
2-Isobutyl-1h-imidazole
AA00EE8G | MFCD15146457
63271-86-3
63271-86-3
3-Mercaptophenylacetic acid
AA00EECU | MFCD00797616
59989-18-3
59989-18-3
5-ethynyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
AA00EEK6 | MFCD00871973
59403-54-2
59403-54-2
1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine
AA00EEPB | MFCD00674327
58837-31-3
58837-31-3
3-(2-Chloroethyl)-2,7-dimethyl-(4H)-pyrido-(1,2a]
AA00EEVG | MFCD00835830
65367-95-5
65367-95-5
4-(2-Methylphenoxy)piperidine, HCl
AA00EF1M | MFCD03840132
Submit
© 2017 AA BLOCKS, INC. All rights reserved.